The US’s new surge in coronavirus cases, explained (vox.com)

The US’s new surge in coronavirus cases, explained

America could have prevented another surge in coronavirus cases. It’s now clear it didn’t.

The past week gave America an ugly reminder that the threat of the coronavirus pandemic is far from over. Cases are rapidly rising again. The nation on Wednesday hit a new record for daily new infections, and then hit a new record again and again over the next two days.

Submitted by mo2 on Sat, 06/27/2020 - 20:22

COVID-19 killed the era of 'big' flying (engadget.com)

COVID-19 killed the era of 'big' flying

The future of flying is smaller, more efficient planes.

COVID-19 has shattered the aviation industry, with nations closing their borders and banning all but essential travel. A world where people could hop from country to country is now one where empty planes travel to maintain contractual obligations. Major carriers, including American, IAG, Delta and Lufthansa have all asked for government bailouts.

Submitted by mo2 on Thu, 06/25/2020 - 20:14

Over 3,700 coronavirus tests were done in Connecticut overnight and one percent of the tests have come back positive, according to new numbers released by the state on Sunday.

In total, there have been 393,475 coronavirus tests done in Connecticut, including 3,772 tests done overnight. The percentage of positive tests is one percent.

Submitted by mo2 on Sun, 06/21/2020 - 20:20
Trump’s Tulsa rally: He says he wanted to 'slow the testing down' on COVID-19 and other takeaways

WASHINGTON – President Donald Trump held his first campaign rally since March in Tulsa, Oklahoma, on Saturday after days of speculation about the impact the event would have on spreading the coronavirus and how large the crowd would be. 

Submitted by mo2 on Sun, 06/21/2020 - 20:20
From Oxford to an Italian lab, one race for coronavirus vaccine is gaining backers

POMEZIA, Italy —On a day in mid-March — as the pandemic began to grip the world — a box from Oxford University arrived at a lab south of Rome. In it, packed with dry ice, were several tiny vials. Each one held a few drops of “seed stock,” a starter kit for the production of a potential vaccine for the novel coronavirus. 

The company’s job was to turn a few droplets into an amount large enough for 13,000 people — a sufficient quantity to perform ­large-scale trials unfolding on several continents.

Submitted by mo2 on Sun, 06/21/2020 - 20:12
US halts hydroxychloroquine clinical trial after finding no additional benefit for Covid-19 patients

The National Institutes of Health announced Saturday that it has halted a clinical trial evaluating the safety and effectiveness of drug hydroxychloroquine as a treatment for adults hospitalized with Covid-19.

Submitted by mo2 on Sat, 06/20/2020 - 19:22
Italy sewage study suggests COVID-19 was there in December 2019

LONDON (Reuters) - Scientists in Italy have found traces of the new coronavirus in wastewater collected from Milan and Turin in December 2019 - suggesting COVID-19 was already circulating in northern Italy before China reported the first cases.

The Italian National Institute of Health looked at 40 sewage samples collected from wastewater treatment plants in northern Italy between October 2019 and February 2020. An analysis released on Thursday said samples taken in Milan and Turin on Dec. 18 showed the presence of the SARS-Cov-2 virus.

Submitted by mo2 on Fri, 06/19/2020 - 20:08